Mycopathologia ( IF 3.6 ) Pub Date : 2021-07-05 , DOI: 10.1007/s11046-021-00576-8 Cheng-Yan You 1, 2, 3, 4, 5 , Fang Hu 1, 2, 3, 4, 5 , Si-Wei Lu 1, 2, 3, 4, 5 , Dan-Dan Pi 1, 2, 3, 4, 5 , Feng Xu 1, 2, 3, 4, 5 , Cheng-Jun Liu 1, 2, 3, 4, 5 , Yue-Qiang Fu 1, 2, 3, 4, 5
Background
Talaromyces marneffei (T. marneffei) is a thermally dimorphic fungus causing systemic mycosis. Due to the atypical symptoms and diverse imaging findings, T. marneffei-infected patients may be misdiagnosed thus preventing timely antifungal therapy. Moreover, HIV-negative patients with T. marneffei infection may be congenitally immunocompromised because of the mutation of immune-related genes.
Case presentation
We describe a case of an HIV-negative child who developed disseminated T. marneffei infection in a nonendemic area. Chest CT showed similar imaging changes of miliary pulmonary tuberculosis, while there was no other evidence of tuberculosis infection, and empirical antituberculosis treatment was not effective. Lymphocyte subset analysis showed reduced natural killer cells, and the immunoglobulin profile showed low levels of IgM, C3 and C4. A bone marrow smear revealed T. marneffei infection, and ascites culture also proved T. marneffei infection. Despite antifungal treatment, the child died of multiple organ failure. Two gene mutations in caspase recruitment domain-containing protein 9 (CARD9) were detected, which had not been reported previously in T. marneffei-infected patients.
Conclusions
HIV-negative patients with CARD9 mutations may be potential hosts of T. marneffei. Abnormalities in the immunoglobin profile and lymphocyte subset may provide clues for immunocompromised patients, and further genetic testing is advised to identify gene mutations in HIV-negative patients with T. marneffei infection.